Together, these findings indicate that SAA promotes insulin resistance through receptor-mediated mechanisms, most likely involving NF-κB-driven disruption of the IRS-1/PI3K/Akt signaling cascade, a hypothesis that requires validation in clinical settings to establish its translational relevance. Here, SAA2 is linked to Insulin resistance.